• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HSV-1 activation of HIV-1 transcription is augmented by a cellular protein that binds near the initiator element.

作者信息

Margolis D M, Ostrove J M, Straus S E

机构信息

Program in Molecular Medicine, University of Massachusetts Medical Center, Worcester 01605.

出版信息

Virology. 1993 Jan;192(1):370-4. doi: 10.1006/viro.1993.1046.

DOI:10.1006/viro.1993.1046
PMID:8390764
Abstract

A cellular DNA binding protein, which we term Leader Binding Protein-2 (LBP-2), binds near the transcriptional initiation site of the human immunodeficiency virus type 1 (HIV-1) promoter. This protein recognizes a motif similar to that of LBP-1, a putative repressor of transcription (Kato, H., et al., Science, 251, 1476-1479, 1991). LBP-2 is associated with transcriptional activation of HIV-1 by herpes simplex virus type 1 (HSV-1). Electrophoretic mobility shift assays showed that nuclear levels of this protein increase markedly following HSV-1 infection. Mutations of the LBP binding motif eliminate LBP-2 binding and interfere with HIV-1 activation by HSV-1. When inserted into an unrelated promoter, this motif confers transcriptional responsiveness to HSV-1 infection. Proteins that bind near the initiator element may be important regulators of HIV-1 gene expression.

摘要

相似文献

1
HSV-1 activation of HIV-1 transcription is augmented by a cellular protein that binds near the initiator element.
Virology. 1993 Jan;192(1):370-4. doi: 10.1006/viro.1993.1046.
2
Repression of the human immunodeficiency virus type-1 long terminal repeat by the c-Myc oncoprotein.c-Myc癌蛋白对人类免疫缺陷病毒1型长末端重复序列的抑制作用。
J Cell Biochem. 2004 May 15;92(2):400-13. doi: 10.1002/jcb.20065.
3
Identification of human cytomegalovirus target sequences in the human immunodeficiency virus long terminal repeat. Potential role of IE2-86 binding to sequences between -120 and -20 in promoter transactivation.在人类免疫缺陷病毒长末端重复序列中鉴定人巨细胞病毒靶序列。IE2 - 86结合至启动子反式激活中 - 120至 - 20之间序列的潜在作用。
J Hum Virol. 1999 Mar-Apr;2(2):81-90.
4
Role of glucocorticoid receptor binding sites in the human immunodeficiency virus type 1 long terminal repeat in steroid-mediated suppression of HIV gene expression.糖皮质激素受体结合位点在人类免疫缺陷病毒1型长末端重复序列中对类固醇介导的HIV基因表达抑制作用的角色。
Virology. 1995 Dec 20;214(2):512-21. doi: 10.1006/viro.1995.0062.
5
Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein.HIV-1核衣壳蛋白增强HIV-1长末端重复序列的基础水平活性。
Virology. 2000 Mar 15;268(2):251-63. doi: 10.1006/viro.2000.0194.
6
Tackling Tat.应对反式激活转录蛋白
J Mol Biol. 1999 Oct 22;293(2):235-54. doi: 10.1006/jmbi.1999.3060.
7
The GGTCA palindrome and cognate cellular factors in trans-regulation of human immunodeficiency virus long terminal repeat by herpes simplex virus.
J Gen Virol. 1993 Apr;74 ( Pt 4):715-23. doi: 10.1099/0022-1317-74-4-715.
8
NF-kappa B-binding proteins induced by HSV-1 infection of U937 cells are not involved in activation of human immunodeficiency virus.单纯疱疹病毒1型感染U937细胞诱导产生的核因子κB结合蛋白不参与人类免疫缺陷病毒的激活。
Virology. 1993 Feb;192(2):491-500. doi: 10.1006/viro.1993.1065.
9
Tat-dependent repression of human immunodeficiency virus type 1 long terminal repeat promoter activity by fusion of cellular transcription factors.通过细胞转录因子融合实现的人免疫缺陷病毒1型长末端重复序列启动子活性的Tat依赖性抑制
Biochem Biophys Res Commun. 2004 Sep 17;322(2):614-22. doi: 10.1016/j.bbrc.2004.07.165.
10
The X protein of HBV induces HIV-1 long terminal repeat transcription by enhancing the binding of C/EBPβ and CREB1/2 regulatory proteins to the long terminal repeat of HIV-1.HBV 的 X 蛋白通过增强 C/EBPβ 和 CREB1/2 调节蛋白与 HIV-1 长末端重复序列的结合,诱导 HIV-1 长末端重复转录。
Virus Res. 2011 Mar;156(1-2):81-90. doi: 10.1016/j.virusres.2011.01.001. Epub 2011 Jan 12.

引用本文的文献

1
HSV1-induced enhancement of productive HIV-1 replication is associated with interferon pathway downregulation in human macrophages.单纯疱疹病毒 1 诱导的人类巨噬细胞中 HIV-1 复制的增强与干扰素通路下调有关。
Mem Inst Oswaldo Cruz. 2024 Oct 28;119:e240102. doi: 10.1590/0074-02760240102. eCollection 2024.
2
HIV Expression in Infected T Cell Clones.HIV 在感染的 T 细胞克隆中的表达。
Viruses. 2024 Jan 11;16(1):108. doi: 10.3390/v16010108.
3
Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial.
长期阿昔洛韦抑制疗法对坦桑尼亚女性生殖器和血浆 HIV RNA 的影响:一项随机对照试验。
J Infect Dis. 2010 May 1;201(9):1285-97. doi: 10.1086/651696.
4
Mitogen-activated protein kinases regulate LSF occupancy at the human immunodeficiency virus type 1 promoter.丝裂原活化蛋白激酶调节人免疫缺陷病毒1型启动子处的LSF占据情况。
J Virol. 2005 May;79(10):5952-62. doi: 10.1128/JVI.79.10.5952-5962.2005.
5
Regulation of HIV-1 transcription.HIV-1转录的调控
Gene Expr. 1999;8(2):67-84.
6
Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site.1型单纯疱疹病毒编码的ICP0与反式激活因子(Tat)之间的合作,以支持1型人类免疫缺陷病毒长末端重复序列在体内的转录,这种合作可以在没有TAR结合位点的情况下发生。
J Virol. 1996 Oct;70(10):6937-46. doi: 10.1128/JVI.70.10.6937-6946.1996.
7
Differential contribution of herpes simplex virus type 1 gene products and cellular factors to the activation of human immunodeficiency virus type 1 provirus.单纯疱疹病毒1型基因产物和细胞因子对人类免疫缺陷病毒1型前病毒激活的差异作用。
J Virol. 1993 Jul;67(7):4427-31. doi: 10.1128/JVI.67.7.4427-4431.1993.
8
Human transcription factor YY1 represses human immunodeficiency virus type 1 transcription and virion production.人类转录因子YY1可抑制1型人类免疫缺陷病毒的转录及病毒体产生。
J Virol. 1994 Feb;68(2):905-10. doi: 10.1128/JVI.68.2.905-910.1994.
9
The herpes simplex virus type 1 major capsid protein (VP5-UL19) promoter contains two cis-acting elements influencing late expression.单纯疱疹病毒1型主要衣壳蛋白(VP5-UL19)启动子包含两个影响晚期表达的顺式作用元件。
J Virol. 1994 Sep;68(9):5738-47. doi: 10.1128/JVI.68.9.5738-5747.1994.
10
Antiviral therapy for human immunodeficiency virus infections.人类免疫缺陷病毒感染的抗病毒治疗。
Clin Microbiol Rev. 1995 Apr;8(2):200-39. doi: 10.1128/CMR.8.2.200.